Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Model-based Strategy to Guide the Choice of Clinical Doses for ADC

Posted on October 14th, 2020 by

Chemotherapy has been a powerful method for fighting cancer for decades. One of the most effective therapies available, it is also known for weakening the patient and causing harsh side effects like pain, nausea, and hair loss. This is because in its zeal to attack cancer cells, chemo also kills healthy cells.

(more…)

How DNA-encoded Libraries Boost Drug Discovery

Posted on October 7th, 2020 by

DNA-encoded libraries (DELs) have been gaining a lot of traction in hit finding and drug discovery in recent years. Regarded by some as a truly revolutionary advance in chemistry, a DEL is a mixture of millions of small molecules in which each molecule is conjugated to a DNA-oligomer that encodes its chemical structure. The mixture can be stored in a simple test tube.

(more…)

Complimentary trend analysis report: Emerging trends in pancreatic cancer research

Posted on September 17th, 2020 by

Pancreatic cancer sadly remains one of the most deadly cancers in existence, partly because it often goes undiagnosed until it has already metastasized. Finding new and better therapies to fight pancreatic cancer means accelerating the research. A new report just released from Elsevier’s Professional Services Group, titled Text mining to identify emerging trends in the pancreatic cancer literature, shows how that is possible.

(more…)

Insights begin with clean, reusable data

Posted on August 24th, 2020 by

Good data practices lead to better research outcomes. To learn more about why clean, reusable data is critical to R&D, take a look at this helpful new infographic that demonstrates how Entellect is centered around the importance of reusable data, irrespective of scientific domain.

(more…)

  1. 1
  2. 2
  3. 3
  4. 84